Table 1 Patient characteristics at time of diagnosis.

From: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

 

SP142 n = 68

SP263 n = 76

Patient age–med (range) Year

57 (33–84)

56 (32–90)

Race – No. (%)

  White

37 (54.4)

38 (50)

  Black

31 (45.6)

38 (50)

Stained Tissue – No. (%)

  Primary tumor

68 (100)

76 (100)

  Metastatic tumor

0 (0)

0 (0)

Pathologic Stage – No. (%)

  T1a

0 (0)

0 (0)

  T1b

2 (2.9)

2 (2.6)

  T1c

29 (42.6)

31 (40.8)

  T2

33 (48.5)

39 (51.3)

  T3

2 (2.9)

2 (2.6)

  T4

2 (2.9)

2 (2.6)

  NX

3 (4.4)

3 (3.9)

  N0

41 (60.3)

44 (57.9)

  N1

18 (26.4)

23 (30.2)

  N2

5 (7.3)

5 (6.7)

  N3

1 (1.5)

1 (1.3)